| Literature DB >> 26358570 |
Mani Arsalan1,2, Thomas Walther1, Robert L Smith1,2, Paul A Grayburn1,2.
Abstract
Tricuspid regurgitation (TR) is the most common lesion of the tricuspid valve (TV). Mild TR is common and usually is benign. However, moderate or severe TR can lead to irreversible myocardial damage and adverse outcomes. Despite these findings, few patients with significant TR undergo surgery. The treatment of functional (secondary) TR in particular remains controversial because of high rates of residual or recurrent TR and poor outcomes following surgical intervention. Traditional teaching that functional TR resolves on its own if the underlying disease is successfully treated has proven to be incorrect. This review aims to clarify management of TR by describing the anatomy, pathophysiology, diagnosis, and treatment of TR, including the eventual possibility of percutaneous TV therapy. Published on behalf of the European Society of Cardiology. All rights reserved.Entities:
Keywords: Cardiac surgery; Tricuspid regurgitation; Valvular heart disease
Mesh:
Year: 2017 PMID: 26358570 DOI: 10.1093/eurheartj/ehv487
Source DB: PubMed Journal: Eur Heart J ISSN: 0195-668X Impact factor: 29.983